This inventor holds 2 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignee: Amgen Inc.. Active years: 2004-2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2004-2015
Title: Paul Kostenuik: Innovator in Bone Disease Treatment
Introduction
Paul Kostenuik is a notable inventor based in Newbury Park, CA (US). He has made significant contributions to the field of biomedical research, particularly in the treatment of bone diseases. With a total of 2 patents, his work has had a meaningful impact on medical science.
Latest Patents
Kostenuik's latest patents include innovative chimeric molecules that combine receptor activator of NF-κB ligand (RANKL) antibodies with parathyroid hormone/parathyroid hormone-related protein (PTH/PTHrP) peptides. These compositions and methods are designed for the treatment of various bone diseases. Additionally, he has developed modulators of receptors for parathyroid hormone and parathyroid hormone-related protein, further advancing therapeutic options in this area.
Career Highlights
Throughout his career, Kostenuik has been associated with Amgen Inc., a leading biotechnology company. His work at Amgen has allowed him to collaborate with other experts in the field and contribute to groundbreaking research.
Collaborations
Some of his notable coworkers include Chuan-Fa Liu and David L Lacey. Their collaborative efforts have enhanced the research and development of innovative treatments for bone-related conditions.
Conclusion
Paul Kostenuik's contributions to the field of bone disease treatment through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in medical therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile